Korean J Physiol Pharmacol.  2019 Sep;23(5):357-366. 10.4196/kjpp.2019.23.5.357.

Identification of phospholipase C β downstream effect on transient receptor potential canonical 1/4, transient receptor potential canonical 1/5 channels

  • 1Department of Physiology, Seoul National University College of Medicine, Seoul 03080, Korea. insuk@snu.ac.kr
  • 2Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195, USA.


Gα(q)-coupled receptor stimulation was implied in the activation process of transient receptor potential canonical (TRPC)1/4 and TRPC1/5 heterotetrameric channels. The inactivation occurs due to phosphatidylinositol 4,5-biphosphate (PI(4,5)Pâ‚‚) depletion. When PI(4,5)Pâ‚‚ depletion was induced by muscarinic stimulation or inositol polyphosphate 5-phosphatase (Inp54p), however, the inactivation by muscarinic stimulation was greater compared to that by Inp54p. The aim of this study was to investigate the complete inactivation mechanism of the heteromeric channels upon Gα(q)-phospholipase C β (Gα(q)-PLCβ) activation. We evaluated the activity of heteromeric channels with electrophysiological recording in HEK293 cells expressing TRPC channels. TRPC1/4 and TRPC1/5 heteromers undergo further inhibition in PLCβ activation and calcium/protein kinase C (PKC) signaling. Nevertheless, the key factors differ. For TRPC1/4, the inactivation process was facilitated by Ca²âº release from the endoplasmic reticulum, and for TRPC1/5, activation of PKC was concerned mostly. We conclude that the subsequent increase in cytoplasmic Ca²âº due to Ca²âº release from the endoplasmic reticulum and activation of PKC resulted in a second phase of channel inhibition following PI(4,5)Pâ‚‚ depletion.


Calcium; GTP-binding proteins; Protein kinase C; Transient receptor potential channels; Type C phospholipases
Full Text Links
  • KJPP
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr